A Clinical Trial of STP0404 in Treatment-Naïve Adults With HIV-1 Infection
Status:
Not yet recruiting
Trial end date:
2024-05-08
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the antiviral effect, safety, tolerability, and
pharmacokinetics of STP0404 in treatment naïve adult participants living with Human
Immunodeficiency Virus Type 1 (HIV-1) infection.